Kyntra Bio, Inc. (KYNB)
6.99
+0.05
(+0.72%)
USD |
NASDAQ |
May 22, 16:00
6.98
-0.01
(-0.14%)
After-Hours: 20:00
Kyntra Bio EPS Diluted (Quarterly) : -3.755 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anixa Biosciences, Inc. | -0.0772 |
| GT Biopharma, Inc. | -0.1112 |
| Perspective Therapeutics, Inc. | -0.2528 |
| XOMA Royalty Corp. | 0.173 |
| Gossamer Bio, Inc. | -0.1993 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.13M |
| Revenue (Quarterly) | 3.738M |
| Total Expenses (Quarterly) | 18.87M |
| Enterprise Value | -5.223M |
| Gross Profit Margin (Quarterly) | -10.03% |
| Profit Margin (Quarterly) | -404.8% |
| Earnings Yield | 392.9% |
| Normalized Earnings Yield | 410.36 |